Latest Breaking News On - Blue earth diagnostics - Page 5 : comparemela.com

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomClare gidleyMike beyerDavide gaudenScintomics gmbAsheshb janiPriscilla harlanSam brown incStudy groupCorporate communicationsNuclear medicineWinship cancer institute of emory universitySolutions incBracco groupTechnical university of munichA siemens healthineers company

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prost

− Post-hoc analysis from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial provides data about treatment planning, particularly when curative salvage therapy is considered –For U.S audiences onlyMONROE TOWNSHIP, N.J. & OXFORD, England (BUSINESS WIRE) Blue Earth Diagnostics, a Bracco company and recognized leader in.

United kingdomScintomics gmbClare gidleyPriscilla harlanAsheshb janiMike beyerStudy groupSam brown incDrug administrationBracco groupTechnical university of munichNuclear medicineWinship cancer institute of emory universityCorporate communicationsBlue earth diagnostic phaseBlue earth diagnostics

Additional Results of POSLUMA® (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Additional Results of POSLUMA® (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomDavide gaudenGarya ulanerClare gidleyPriscilla harlanPhilliph kuoLos angelesScintomics gmbMike beyerUniversity of arizonaDrug administrationHoag family cancer instituteTechnical university of munichBracco groupA siemens healthineers companyStudy group

Blue Earth Diagnostics: Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Blue Earth Diagnostics: Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomDavide gaudenMike beyerGarya ulanerPriscilla harlanScintomics gmbLos angelesPhilliph kuoClare gidleyCorporate communicationsHoag family cancer instituteNuclear medicineSolutions incA siemens healthineers companyStudy groupDrug administration

Blue Earth Diagnostics Highlights Presentations on POSLUMA® (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

Blue Earth Diagnostics Highlights Presentations on POSLUMA® (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of southern californiaUnited statesSan diegoSan diego convention centerUnited kingdomAshesh janiNicholas zouainMike beyerPriscilla harlanClare gidleyGarya ulanerDavide gaudenPhilliph kuoLos angelesAsheshb janiStudy group